Cargando…

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study

Detalles Bibliográficos
Autores principales:	Vadhan-Raj, Saroj, Ford, David C, Dahl, Naomi V, Bernard, Kristine, Li, Zhu, Allen, Lee F, Strauss, William E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2016
Materias:	E-Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725221/ https://www.ncbi.nlm.nih.gov/pubmed/26572233 http://dx.doi.org/10.1002/ajh.24240

Ejemplares similares

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
por: Vadhan-Raj, Saroj, et al.
Publicado: (2017)

Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron
por: Vadhan-Raj, Saroj, et al.
Publicado: (2014)

A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy
por: Hetzel, David, et al.
Publicado: (2014)

Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
por: Macdougall, Iain C., et al.
Publicado: (2019)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2017)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2018)

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
por: Ford, David C, et al.
Publicado: (2016)

Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy
por: Gerb, Jesse, et al.
Publicado: (2021)

Iron refractory iron deficiency anemia: a heterogeneous disease that is not always iron refractory
por: Donker, Albertine E., et al.
Publicado: (2016)

Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia
por: Derman, Richard, et al.
Publicado: (2018)

Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia
por: Strauss, William E., et al.
Publicado: (2016)

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
por: Adkinson, N. Franklin, et al.
Publicado: (2018)

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA
por: Dahl, Naomi V, et al.
Publicado: (2017)

Hemoglobin response to ferric citrate in patients with nondialysis‐dependent chronic kidney disease and iron deficiency anemia
por: Pergola, Pablo E., et al.
Publicado: (2018)

Iron overload in patients with rare hereditary hemolytic anemia: Evidence‐based suggestion on whom and how to screen
por: van Straaten, Stephanie, et al.
Publicado: (2018)

PB2249: SUCROSOMIAL IRON SUPPORT IN PATIENT WITH IRON DEFICIENCY ANEMIA IS HIGLY EFFECTIVE IN IMPROVING ANEMIA REDUCING ERYPTOSIS AND M1 MACROPHAGES POLARIZATION
por: giordano, G., et al.
Publicado: (2022)

PB2563: IRON DEFICIENCY ANEMIA: A MONOCENTRIC EXPERIENCE OF THE HAEMATOLOGY DEPARTMENT OF MONASTIR, TUNISIA
por: Bouhoula, Donia, et al.
Publicado: (2023)

PB2568: BIERMER’S DISEASE REVEALED BY SPONTANEOUS ABORTIONS AND IRON DEFICIENCY ANEMIA: A CASE REPORT.
por: Hanani, Hind, et al.
Publicado: (2023)

Predicting serum ferritin levels in patients with iron overload treated with the film‐coated tablet of deferasirox during the ECLIPSE study
por: Taher, Ali T., et al.
Publicado: (2018)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
por: Adkinson, N Franklin, et al.
Publicado: (2017)

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review
por: Glaspy, John A, et al.
Publicado: (2020)

Oxidation of ferumoxytol by ionizing radiation releases iron. An electron paramagnetic resonance study
por: Petronek, Michael S, et al.
Publicado: (2022)

Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains
por: Theruvath, Ashok Joseph, et al.
Publicado: (2020)

Genetic variants at HbF‐modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania
por: Mtatiro, Siana Nkya, et al.
Publicado: (2014)

Unsatisfactory Laws
Publicado: (1890)

PB2250: GENETIC REGULATION IN IRON OMEOSTASIS IN SIDEROPENIC COVID19 DISEASE AFFECTED PATIENTS WITH NEW IRON ORAL FORMULATION: LESSONS FROM A DIFFERENT PERSPECTIVE
por: giordano, G., et al.
Publicado: (2022)

PB2567: THE EFFECT OF BLOOD DONATIONS ON IRON DEFICIENCY IN BLOOD DONORS
por: Lastochkina, Daria, et al.
Publicado: (2023)

Iron-Refractory Iron Deficiency Anemia
por: Yılmaz Keskin, Ebru, et al.
Publicado: (2015)

Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia
por: Acaster, Sarah, et al.
Publicado: (2015)

PB2565: TRANSFUSIONAL IRON OVERLOAD AND ASSOCIATED COMPLICATIONS IN HEMATOLOGY DISORDERS PATIENTS
por: Romanenko, Nikolay, et al.
Publicado: (2023)

PB1748: DIFFERENTIAL IRON HOMEOSTASIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN VITRO MODELS
por: Capelletti, M. M., et al.
Publicado: (2022)

PB2533: FREQUENCY, PATTERN, AND CLINICAL CORRELATES OF RENAL IRON ACCUMULATION IN THALASSEMIA MAJOR
por: Meloni, Antonella, et al.
Publicado: (2023)

5573836 CLINICOHEMATOLOGICAL CHARACTERISTICS OF IRON DEFICIENCY ANEMIA AND HEMOGLOBINOPATHIES IN PAKISTAN;AN EXPERIENCE OF NON HOSPITAL BASED LABORATORY
por: Aisha Arshad, A.A., et al.
Publicado: (2023)

Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron
por: Strauss, William E, et al.
Publicado: (2018)

The Unsatisfactory Panel System
Publicado: (1913)

IRON METABOLISM IN EXPERIMENTAL ANEMIA : "AVAILABILITY OF IRON"
por: Hahn, P. F., et al.
Publicado: (1938)

Iron deficiency and iron deficiency anemia in pregnancy
por: Malinowski, A. Kinga, et al.
Publicado: (2021)

PB2566: EPIDEMIOLOGICAL PROFILE AND INDICATIONS FOR IV IRON THERAPY: A TRANSFUSION SPARING ALTERNATIVE
por: Laabichi, Amine, et al.
Publicado: (2023)

Iron, Anemia, and Iron Deficiency Anemia among Young Children in the United States
por: Gupta, Priya M., et al.
Publicado: (2016)

Hepcidin and iron parameters in children with anemia of chronic disease and iron deficiency anemia
por: Mahajan, Gunjan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8njmlphfcd89t6kh2lrfjndthg